Medicare Enrolled
Dr. Aron Rubin, MD
Pulmonary Disease · Brooklyn, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rubin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rubin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rubin
Dr. Aron Rubin is a pulmonary disease specialist in Brooklyn, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rubin performed 21,026 Medicare services across 3,911 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rubin received a total of $16,237 from 32 pharmaceutical and/or device companies across 645 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rubin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 0% volume in NY
$16,237 industry payments
Medicare Practice Summary
Medicare Utilization ↗21,026
Medicare services
Top 0% in NY for pulmonary disease
3,911
Unique beneficiaries
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,051 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Allergy skin test A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens. |
16,040 | $4 | $8 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
782 | $80 | $160 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
695 | $114 | $221 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
568 | $53 | $106 |
| Lung volume measurement test A test that measures the largest amount of air you can breathe in and out. It evaluates the total capacity of your lungs. |
567 | $14 | $31 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
562 | $41 | $83 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
510 | $25 | $51 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
377 | $72 | $135 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
179 | $149 | $291 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
125 | $8 | $13 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
100 | $17 | $39 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
86 | $98 | $198 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
75 | $13 | $25 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
75 | $120 | $224 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
69 | $36 | $81 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
57 | $79 | $157 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
44 | $109 | $203 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
30 | $13 | $26 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
22 | $51 | $102 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
19 | $49 | $97 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
15 | $158 | $296 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
15 | $17 | $34 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
14 | $36 | $60 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$16,237
Total received (2018-2024)
Avg $2,320/year across 7 years
Top 13% in NY for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
645
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,954 (98.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$283 (1.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,061
2023
$2,251
2022
$2,246
2021
$2,321
2020
$1,758
2019
$1,971
2018
$2,630
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$657
GENZYME CORPORATION
$613
Mylan Specialty L.P.
$443
Regeneron Healthcare Solutions, Inc.
$324
GlaxoSmithKline, LLC.
$278
Philips North America LLC
$228
Boehringer Ingelheim Pharmaceuticals, Inc.
$199
Regeneron Pharmaceuticals, Inc.
$134
Takeda Pharmaceuticals U.S.A., Inc.
$75
E.R. Squibb & Sons, L.L.C.
$45
Insmed, Inc.
$41
Amgen Inc.
$23
Top 3 companies account for 56.0% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$2,940
AstraZeneca Pharmaceuticals LP
$2,716
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,246
GENZYME CORPORATION
$1,532
Mylan Specialty L.P.
$1,219
Regeneron Healthcare Solutions, Inc.
$1,121
Genentech USA, Inc.
$789
Regeneron Pharmaceuticals, Inc.
$634
E.R. Squibb & Sons, L.L.C.
$329
BOSTON SCIENTIFIC CORPORATION
$265
Insmed, Inc.
$258
Philips North America LLC
$228
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$219
Circassia Pharmaceuticals Inc
$219
Novartis Pharmaceuticals Corporation
$179
Amgen Inc.
$143
SANOFI-AVENTIS U.S. LLC
$141
Amarin Pharma Inc.
$133
Electromed, Inc.
$114
Actelion Pharmaceuticals US, Inc.
$106
Inogen, Inc.
$100
Janssen Pharmaceuticals, Inc
$97
OptiNose US, Inc.
$93
Philips Electronics North America Corporation
$91
Sunovion Pharmaceuticals Inc.
$90
Takeda Pharmaceuticals U.S.A., Inc.
$75
Horizon Therapeutics plc
$37
ARBOR PHARMACEUTICALS, INC.
$33
Mallinckrodt Hospital Products Inc.
$28
Paratek Pharmaceuticals, Inc.
$24
PFIZER INC.
$22
United Therapeutics Corporation
$18
Top 3 companies account for 48.7% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ALAIR · ANORO · ANORO ELLIPTA · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · CAMZYOS · CHANTIX · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · ELIQUIS · Edarbi · Esbriet · FARXIGA · FASENRA · GENERAL PULMONARY · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · LONHALA MAGNAIR · NIOX VERO DEVICE · NUCALA · NUZYRA · OFEV · OPSUMIT · PENNSAID · RAYOS · SEEBRI · SHINGRIX · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · TRULANCE · TUDORZA PRESSAIR · TYVASO · UPTRAVI · UTIBRON · Utibron · Vascepa · XARELTO · XIFAXAN · XOLAIR · Xhance · Xolair · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
608
Per 100K population
23.0
County median income
$78,548
Nearest hospital
SOUTH BROOKLYN HEALTH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rubin is a mixed practice specialist, with above-average Medicare volume (top 0% in NY), with low-engagement industry engagement in the top 13% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rubin experienced with allergy skin test?
Based on Medicare claims data, Dr. Rubin performed 16,040 allergy skin test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rubin receive payments from pharmaceutical companies?
Yes. Dr. Rubin received a total of $16,237 from 32 companies across 645 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rubin's costs compare to other pulmonary diseases in Brooklyn?
Dr. Rubin's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rubin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Brooklyn
Browse pulmonary diseases in Brooklyn ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NY
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NY
Which NY pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology